论文部分内容阅读
目的探讨奥司他韦联合炎琥宁治疗小儿病毒性肺炎的临床疗效。方法选取2014年2月—2016年2月河南医学高等专科学校附属医院收治的病毒性肺炎患儿124例,随机分为炎琥宁组与研究组,各62例。研究组患儿予以奥司他韦联合炎琥宁治疗,炎琥宁组予以炎琥宁抗病毒治疗。观察两组患儿临床疗效、不良反应发生情况。结果研究组总有效率高于炎琥宁组,差异有统计学意义(P<0.05);两组患儿的不良反应发生情况比较,差异无统计学意义(P>0.05)。结论奥司他韦联合炎琥宁治疗小儿病毒性肺炎的临床疗效显著,可改善患儿临床症状,且不良反应少。
Objective To investigate the clinical efficacy of oseltamivir and mesylate in the treatment of children with viral pneumonia. Methods A total of 124 children with viral pneumonia admitted from February 2014 to February 2016 in the Affiliated Hospital of Henan Medical College were randomly divided into Yanhuning group and study group, with 62 cases in each group. The study group was treated with oseltamivir plus memantine, and the Yan-Hun-ning group was treated with antiviral antiviral. To observe the clinical efficacy of two groups of children, the incidence of adverse reactions. Results The total effective rate of study group was higher than that of Yanhuning group, the difference was statistically significant (P <0.05). There was no significant difference between the two groups in the incidence of adverse reactions (P> 0.05). Conclusion The combination of oseltamivir and mesylate can significantly improve the clinical symptoms of children with viral pneumonia, with fewer adverse reactions.